-
·
Published:150 Patients – 150 Times New Hope
We at PRECISIS are proud to announce a major milestone: 150 patients implanted with EASEE® across Europe. This achievement marks a significant step forward in our mission to improve the lives of people living with drug-resistant focal epilepsy. EASEE®, which received its CE mark in September 2022, is now actively implanted by leading epileptologists and neurosurgeons in…
